Middlebrook Pharmaceuticals Report issue

For profit Phase 3
Founded: Westlake TX United States (1999)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2004
NCT00095368
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Advancis Pharmaceutical Corp | Advancis Pharmaceutical Corporation

Active Ingredients

Drugs in Phase 3 Trials (1)

procaine benzylpenicillin (novocaine) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pharyngitis (Phase 3)

Tonsillitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1